IP Verse

Pohl patent opposition analysis

The comprehensive analysis of Pohl opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Pohl

Stay updated with the latest patent oppositions filed by Pohl

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4339284
Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding SameSEIKAGAKU CORPORATIONMay 27, 2026POHLMAN
EP3377534
Treatment Of Lung Cancer Using A Combination Of An Anti-Pd-1 Antibody And An Anti-Ctla-4 AntibodyBRISTOL-MYERS SQUIBB COMPANYMar 18, 2026POHLMAN
EP4138104
Security SystemDORMAKABA DEUTSCHLAND GMBHFeb 13, 2026ASSA ABLOY SICHERHEITSTECHNIK
EP4186407
Liquid Sprayer For A Dishwasher And DishwasherHAIER GERMANY GMBHFeb 28, 2025ARCELIK ANONIM SIRKETI
EP2818163
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT MBHFeb 26, 2025RATIOPHARM
EP4016572
Release ElementDORMAKABA DEUTSCHLAND GMBHJan 17, 2025ASSA ABLOY SICHERHEITSTECHNIK
EP4069368
Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 15, 2025DORRIES
EP3630946
Cell Culture MethodsUCB BIOPHARMADec 23, 2024POHLMAN
EP3530670
Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding SameSEIKAGAKU CORPORATIONNov 22, 2024POHLMAN
EP3110848
Methods For Treating Skin Infection By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Nov 13, 2024DORRIES

Top clients of Pohl

Top companies who are the clients of Pohl

CompanyTotal
POHLMAN30
LEONHARD KURZ STIFTUNG26
DR H ULRICH DORRIES22
ASSA ABLOY SICHERHEITSTECHNIK19
DORRIES5
PFIZER5
ASSA ABLOY SCHWEIZ4
FOUNDATION MEDICINE INC.4
GENERICS UK TRADING MYLAN3
AMGEN3